Neuca S.A.
NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic an… Read more
Neuca S.A. - Asset Resilience Ratio
Neuca S.A. (NEU) has an Asset Resilience Ratio of 0.21% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2005–2024)
This chart shows how Neuca S.A.'s Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Neuca S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 0% |
| Short-term Investments | zł12.51 Million | 0.21% |
| Total Liquid Assets | zł12.51 Million | 0.21% |
Asset Resilience Insights
- Limited Liquidity: Neuca S.A. maintains only 0.21% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Neuca S.A. Industry Peers by Asset Resilience Ratio
Compare Neuca S.A.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950 |
Medical Distribution | 0.00% |
|
Shenzhen Glory Medical Co Ltd
SHE:002551 |
Medical Distribution | 10.46% |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589 |
Medical Distribution | -4.18% |
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.06% |
|
BCM Alliance Bhd
KLSE:0187 |
Medical Distribution | 17.12% |
|
Qingdao Baheal Medical INC.
SHE:301015 |
Medical Distribution | 3.50% |
|
Excelsior Medical Co Ltd
TW:4104 |
Medical Distribution | 3.70% |
|
CHC Healthcare Group
TW:4164 |
Medical Distribution | 0.46% |
Annual Asset Resilience Ratio for Neuca S.A. (2005–2024)
The table below shows the annual Asset Resilience Ratio data for Neuca S.A..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.62% | zł34.16 Million | zł5.51 Billion | +0.34pp |
| 2023-12-31 | 0.28% | zł14.51 Million | zł5.18 Billion | -0.08pp |
| 2022-12-31 | 0.36% | zł17.45 Million | zł4.84 Billion | -0.24pp |
| 2021-12-31 | 0.60% | zł24.62 Million | zł4.12 Billion | +3.50pp |
| 2020-12-31 | -2.90% | zł-104.59 Million | zł3.61 Billion | +0.61pp |
| 2019-12-31 | -3.51% | zł-119.90 Million | zł3.41 Billion | -0.95pp |
| 2018-12-31 | -2.57% | zł-80.05 Million | zł3.12 Billion | -2.61pp |
| 2017-12-31 | 0.04% | zł1.18 Million | zł2.91 Billion | +2.83pp |
| 2016-12-31 | -2.79% | zł-75.01 Million | zł2.69 Billion | -0.98pp |
| 2015-12-31 | -1.81% | zł-48.56 Million | zł2.68 Billion | -7.79pp |
| 2011-12-31 | 5.98% | zł117.88 Million | zł1.97 Billion | +0.52pp |
| 2010-12-31 | 5.46% | zł113.63 Million | zł2.08 Billion | +5.31pp |
| 2009-12-31 | 0.15% | zł3.09 Million | zł2.03 Billion | -1.70pp |
| 2008-12-31 | 1.85% | zł25.02 Million | zł1.35 Billion | +0.42pp |
| 2007-12-31 | 1.43% | zł16.34 Million | zł1.14 Billion | -0.94pp |
| 2006-12-31 | 2.37% | zł12.90 Million | zł543.57 Million | -1.59pp |
| 2005-12-31 | 3.96% | zł14.70 Million | zł371.26 Million | -- |